STAT

9 articles in the TruthFoundry index. Each links out to the original.

• American Diabetes Association removes chief medical officer amid ongoing review · ADA chief scientific and medical officer Rita Kalyani departs immediately during internal review.
• Eli Lilly loses contract trial; FDA nominee avoids Senate stances · Eli Lilly ordered to pay Nektar $90M; FDA nominee dodges confirmation hearing questions.
• Kura Oncology Spinoff Caspian Therapeutics Targets Diabetes with Leukemia Drug Data · Kura Oncology launches Caspian Therapeutics to develop menin inhibitors for diabetes treatment.
• ADA CEO: Independent Review Clears Association of Suppressing Views or Calling Police · ADA CEO Charles Henderson states an independent review found no evidence of viewpoint suppression or police involvement at the June conference.
• Diabetes patient uses unapproved open-source software with improved health results · Author Dana Goldman manages type 1 diabetes using unregulated open-source insulin software.
• Michigan Supreme Court allows state insulin pricing probe against Eli Lilly · Michigan Supreme Court ruled 4-3 to permit attorney general investigation of Eli Lilly insulin pricing.
• American Diabetes Association criticized over meeting physician evictions · Former award-giving authors condemn ADA for evicting critical physicians at 2026 meeting.
• American Diabetes Association faces resignation calls over expert expulsions · Over 200 ADA members demand leadership resign after five experts were expelled.
• PCOS renamed PMOS, raising care hopes for Black and Latina women · Formerly PCOS, renamed PMOS may reduce diagnostic delays for women of color.